Ibuprofen; no evidence preventing use during COVID-19

The updated position from the National Health Services (NHS), Medicines & Healthcare Products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) confirms that patients can take ibuprofen when self-medicating for symptoms of COVID-19, such as fever and headache.

Ibuprofen is a well-established medicine with a good safety profile that has been used as a self-care fever and pain reducer for more than 30 years.

We will of course be reviewing and looking-out for any new evidence that is published and letting pharmacists and their teams know if things change.


Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.